Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

ClinicalTrials.gov ID: NCT03682302

Public ClinicalTrials.gov record NCT03682302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postsurgical Analgesia in Pediatric Subjects Aged 6 to Less Than 17 Years

Study identification

NCT ID
NCT03682302
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
98 participants

Conditions and interventions

Interventions

  • Exparel Drug
  • 0.5% Bupivacaine HCl Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2019
Primary completion
Aug 29, 2019
Completion
Sep 23, 2019
Last update posted
Jan 5, 2021

2019

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Loma Linda University Loma Linda California 92354
Shriners Hospitals for Children, Northern California Sacramento California 95817
Stanford University Stanford California 94305
Children's Hospital Colorado Aurora Colorado 80045
Nemours / Alfred I. DuPont Hospital for Children Wilmington Delaware 19803
Nicklaus Children's Hospital Miami Florida 33155
Shriners Hospitals for Children-Chicago Chicago Illinois 60707
Riley Hospital for Children at Indiana University Health Indianapolis Indiana 46204
University of Minnesota Masonic Children's Hospital Minneapolis Minnesota 55454
Duke University Medical Center Durham North Carolina 27710
Wake Forest Baptist Health Winston-Salem North Carolina 27157
Cleveland Clinic Cleveland Ohio 44195
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73110
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
McGovern Medical School at UTHealth Houston Texas 77030
Southwest Scoliosis Institute Plano Texas 75075
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03682302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03682302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →